Cambridge, Massachusetts has seen its share of smart people doing smart things, but Synthpop, Inc. feels less like a lab experiment and more like a late night studio session where the beat finally locks. Founded in 2023 by Elad Ferber and Jan Jannink, PhD, this is healthcare AI built by operators who have lived the paperwork pain and decided boredom was no longer an acceptable outcome.
The headline landed February 4, 2026. Synthpop raised a $15 million Series A, pushing total funding to $23 million, led by Ansa Capital with Defy.vc, Peterson Ventures, Storm Ventures, and Bruce Broussard stepping in. Marco DeMeireles from Ansa Capital joined the board, a quiet signal that this round was less about belief and more about scale.
Synthpop’s pitch is simple and dangerous in the best way. Healthcare is drowning in administrative work that steals time, money, and morale. Synthpop built an agentic automation platform that lets document intelligence, payer-aware reasoning, and conversational voice agents work together instead of tripping over each other. Think fewer hold tones, fewer faxes, fewer humans doing robot work.
The numbers are where the rhythm tightens. Over two million patients already processed. Eight major EHR integrations live. Forty minute workflows crushed down to under a minute. Costs running five times lower than traditional human labor. Up to eighty percent of administrative processes automated without breaking compliance or trust.
Elad Ferber knows this movie. Before Synthpop, he co-founded Spry Health and took it through acquisition by ZOLL Itamar. Jan Jannink, PhD brings decades of scalable systems experience from imeem, VoiceBase, Camio, and Stanford classrooms that quietly trained founders you definitely recognize. This is not theory. This is muscle memory.
The bench matters too. Drew Copeland runs operations with two decades of healthcare experience. Chip Smith brings DME credibility earned the hard way. The airt team joined through acquisition, with Davor Runje and Hajdi Cenan adding agentic firepower shaped by real-world deployments and open source impact.
Synthpop is not selling AI hype. It is selling time back to providers, clarity back to payers, and momentum back to patients. The Series A capital is earmarked for deeper integrations, broader vertical reach, and a system that keeps learning how healthcare actually behaves when nobody is watching.
